Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01000259 · ClinicalTrials.gov registry record
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
A clinical trial of Stage IV Ovarian Cancer and Stage IIIA Ovarian Cancer, sponsored by Gynecologic Oncology Group.
- Recruiting
- Registry status
- 174
- Enrollment target
- 1
- Study location
NCT01000259 is a study of Stage IV Ovarian Cancer and Stage IIIA Ovarian Cancer that is actively recruiting participants, run by Gynecologic Oncology Group. The registered enrollment target is 174 participants, above the 63-participant average among 5 other Stage IV Ovarian Cancer trials with a reported enrollment target (176% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01000259, a study of Stage IV Ovarian Cancer and Stage IIIA Ovarian Cancer, is actively recruiting participants, sponsored by Gynecologic Oncology Group.
- RECRUITING
- Registry status
- 174 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study is looking at tumor tissue samples from patients who have undergone surgery for advanced stage III or stage IV ovarian epithelial cancer. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn how tumor infiltrating T cells can predict how patients will respond to treatment.
Conditions Studied
Interventions
- OTHER Laboratory Biomarker Analysis
Study Locations (1)
Pennsylvania
- Gynecologic Oncology Group - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 174 participants |
| Start Date | 2004-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01000259
The ClinicalTrials.gov registry entry for NCT01000259 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 174 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 63-participant average among 5 other Stage IV Ovarian Cancer trials with a reported enrollment target (176% higher). The listed sponsor is Gynecologic Oncology Group, which has 154 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Stage IV Ovarian Cancer appearing as the primary indexed condition, and to 1 intervention - of which Laboratory Biomarker Analysis is the first listed.
NCT01000259 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT01000259 about?
NCT01000259 is a clinical study titled "Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer". This research study is looking at tumor tissue samples from patients who have undergone surgery for advanced stage III or stage IV ovarian epithelial cancer. Studying samples of tumor tissue from patients with cancer in the laboratory may help doctors learn how tumor infiltrating T cells can predict...
What is the current status of trial NCT01000259?
This trial is currently recruiting. The enrollment target is 174 participants. The study started on 2004-09.
What conditions does trial NCT01000259 study?
This clinical trial studies the following conditions: Stage IV Ovarian Cancer, Stage IIIA Ovarian Cancer, Stage IIIB Ovarian Cancer, Stage IIIC Ovarian Cancer.
What interventions are being tested in trial NCT01000259?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER).
Who is sponsoring clinical trial NCT01000259?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01000259 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage IV Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
RECRUITING · Phase 3
-
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
RECRUITING · NA
-
HOT: HIPEC in Ovarian Cancer as Initial Treatment
ACTIVE NOT RECRUITING · Phase 2
-
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy
ACTIVE NOT RECRUITING · NA
-
Salvage Ovarian FANG™ Vaccine + Bevacizumab
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.